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 Our group recently discovered and developed a diastereoselective reaction yielding 
C3-quaternary indolenines from the combination of α,β-unsaturated N-aryl ketonitrones 
and mono- or di-activated alkynes in toluene at 80 °C. This reaction builds a high level 
of complexity in a single step, and the C3-quaternary indolenines produced show 
promise as precursors to indole-containing molecules of biological and medicinal 
interest. However, we found our substrate scope was limited by the methods available 
for the synthesis of the α,β-unsaturated N-aryl ketonitrones necessary for the reaction. 
 As a result of this need, we sought to develop a new way to access these α,β-
unsaturated N-aryl ketonitrones. Our priorities were to develop a method that was 
expedient with regard to time and number of steps, modular, general, and could rely on 
inexpensive commercially available starting materials. The method that we have 
reported proceeds in three steps: starting with a commercially available aniline 
derivative and α,β-unsaturated aldehyde an imine is synthesized and alkylated using an 
organolithium reagent. The resultant secondary amine is then oxidized using Oxone® to 
obtain the α,β-unsaturated N-aryl ketonitrone. Only the nitrone is subject to a discrete 
purification step, and it can generally be isolated in yields of 50-80%. Unfortunately, the 
nitrones generated using this technique would not react with activated alkynes to yield 
indolenines. 
 The two techniques discussed herein offer valuable insight into a poorly understood 




performed make it clear that nitrones are a very viable synthetic intermediate; many 
nitrones can be easily accessed and then used to create very complex molecules in a 
diastereoselective manner. Both of these synthetic techniques in combination offer a 
valuable alternative approach to many complex and biologically interesting indole 
containing alkaloids. It is hoped that this work will serve as fertile ground for further 
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1.1 Structure and Nomenclature 
 
 
Figure 1. General structure of a nitrone. 
 
 Nitrones are the N-oxides of imines (Figure 1). Pfeiffer derived the name nitrone from 
nitrogen ketone, based on his assumption that the reactivity of this new class of 
molecules would be analogous to ketones.
1
 The central structural motif can be described 
as an N-oxide of an imine, although oxidation of imines is not a common strategy for 




 are carbon containing moieties or 
one is a proton, the terms keto-nitrone and aldo-nitrone are used, respectively. In 





 are not identical.  
1.2 History of Nitrones 
 As a class of compounds, nitrones have been known for a very long time. The term 
nitrone was first applied to this functional group by Pfeiffer in 1916 as described above, 
but the first were observed experimentally prior to this by Beckmann as well as Werner 
and Buss in the 1890s.
2




would react analogously to ketones, with the carbon-nitrogen double bond displaying 
similar reactivity to the carbon-oxygen double bond. However, it was subsequently 
established that nitrones behave more like extended ketones; the carbon and oxygen are 
typically the two reactive sites.
3
 Certain trends in nitrone reactivity are both very well 
known and well studied, with the 1,3-dipolar cycloaddition being a rather classic 
example. While discovery of novel avenues of reactivity of nitrones has been extremely 
sporadic over the long span of time since their discovery, many novel methods of 
synthesizing nitrones as well as new applications have been published recently.
4-10
 
 The 1,3-dipolar cycloaddition is a class of well-studied reactions characterized by the 
addition of a 1,3-dipole and a multiple bond dipolarophile to form a five-membered ring. 
Nitrones, potent 1,3-dipoles, are no exception; they will react efficiently with a fairly 
broad range of dipolarophiles, most notably alkenes and alkynes for the large amount of 
attention they have received over the years in methodology studies as well as 
applications in natural product total synthesis (Scheme 1). 
 
 








1.3 Synthesis of Nitrones 
 There are quite a few approaches to synthesize nitrones, which can be roughly divided 
into two major categories based on the reaction type, and then further with regard to the 
starting materials. The first major group involves oxidation of a nitrogenous starting 
material. Imines can be directly oxidized into nitrones in certain cases.
11
 Nitrones can be 
obtained from a broad range of secondary amines when subjected to a variety of 
oxidative conditions.
12
 Hydroxylamines, likely an intermediate in the oxidation of 
secondary amines to nitrones, can themselves be oxidized to nitrones.
13
 The second 
major category of nitrone syntheses is comprised of addition reactions; carbonyl 




1.3.1 Nitrone Synthesis by Oxidation 
 Direct oxidation of imines is a straightforward approach to nitrones, though the scope 
of such a reaction appears at this time relatively limited. An example of a less sensitive 
imine substrate oxidized to the nitrone form by Forrester and colleagues is shown above 
(Scheme 2). Oxidation of imines with peroxyacids generally produces oxaziridines 
which may or may not rearrange to yield the nitrone.
15
 In these cases the nitrone can be 
obtained as a side product or the sole product depending on the substrate and 
conditions
16
. Boyd et al. suggest that the ratio of oxaziridine to nitrone produced during 
peroxyacid oxidation is controlled by the relative frequency of peroxyacids attack on the 
carbon compared to attack by the nitrogen atom.
11
 For example, dimethyl substitution 




formation. Conversely, use of methanol as a solvent greatly increased the yield of 
oxaziridine relative to chlorinated hydrocarbon solvents; this was theorized to result 
from inactivation of the imine nitrogen through hydrogen bonding.  
 
 
Scheme 2. Oxidation of quinone imines to quinone nitrone with m-CPBA. 
 
 
Scheme 3. Oxidation of a secondary amine to the nitrone. 
 
 With the exception of select cases, primary amines cannot be reliably or cleanly 
oxidized to nitrones; complex mixtures are the most typical result.
15
 The second 
commonly used oxidative strategy utilizes secondary amines as the starting material. The 
oxidation of secondary amines to nitrones is far more general than the same reaction for 
imines and can be achieved with a wide variety of different conditions. As a result of 
this, in many cases imines are first reduced or alkylated to yield secondary amines which 
are then oxidized to nitrones. One common set of conditions uses sodium tungstate as a 
catalyst along with excess hydrogen peroxide as oxidant (Scheme 3).
17




reaction conditions is not only clean but in almost all cases provides the nitrone in good 
yields. Variations of this scheme in which the sodium tungstate is replaced by other 
metal oxide catalysts have also been demonstrated to be serviceable.
12,18,19
 Although the 
sodium tungstate-hydrogen peroxide oxidation is the most common, several non-
catalytic oxidizing conditions have been used successfully as well. The urea-hydrogen 
peroxide complex serves as a successful stoichiometric oxidant,
12






Scheme 4. Oxidation of a hydroxylamine to a nitrone using MnO2. 
 
 Another functionality that can be oxidized to the nitrone is the hydroxylamine.
13
 On a 
superficial level, the oxidation to the nitrone is relatively straightforward in contrast to 
imines. The conditions are milder than those required for imines or amines due to the 
oxidation state proximity of the hydroxylamine to the nitrone. There must be a hydrogen 
atom on the α-carbon of any hydroxylamine to be oxidized to the nitrone for obvious 
reasons. Unfortunately, however, the preparation of hydroxylamines is itself not always 
a trivial task; the reactions are usually plagued with a host of side products. In addition 
to these issues, the hydroxylamines are not usually particularly stable compounds. Many 




from hydroxylamine to nitrone,
15
 and additionally mercury (II) oxide and Manganese 
(IV) oxide are also commonly used (Scheme 4).
21
 
1.3.2 Nitrone Synthesis by Addition 
 The other major strategy aside from oxidation to access nitrones is addition. The first 
subcategory in this group is the condensation of carbonyl compounds with N-
monosubstituted hydroxylamines. Hydroxylamines can be directly condensed with 
carbonyl compounds under water-removing conditions to yield nitrones. It has also been 
demonstrated that carbonyl compounds can be condensed with hydroxylamines 
generated in-situ by reduction of nitro compounds.
14
 An intramolecular version of this 
reaction has also been demonstrated to be effective (Scheme 5).
22
 In comparison to 
building a complex and probably unstable hydroxylamine to be oxidized, a simpler 




Scheme 5. In-situ hydroxylamine formation followed by intramolecular condensation 





 The second method to access nitrones through addition reactions takes advantage of 
the functional similarity of oximes to nitrones. One common variety, sometimes known 
as Grigg’s nitrone formation,23 utilizes alkenes activated by electron withdrawing 
groups. The hydroxylamine undergoes a Michael addition to the alkene, at least 
formally. Despite the name of this reaction, the nitrone is often only an intermediate 
generated in situ for a 1,3-dipolar cycloaddition reaction with another the dipolarophile. 
This is the case in Grigg’s original work; the nitrones generated reacted intramolecularly 
and spontaneously after formation to yield isoxazolidines (Scheme 6).  
 
 
Scheme 6. Cyclization of nitrone generated from and oxime and an activated alkyne. 
 
 However, Heaney has shown that unsaturated oximes can be synthesized that will 
react in an intramolecular manner and stop reacting upon reaching the nitrone.
23
 In 
addition, Nakama et al. have shown that nitrones can be formed terminally by the 
intermolecular Lewis Acid-catalyzed reaction between oximes and activated alkenes 
(Scheme 7).
24
 Oximes with a large variety of side chains were successfully reacted with 
simple vinylic ketones, esters, aldehydes and carbamates, demonstrating the potential of 






Scheme 7. Lewis Acid-catalyzed condensation of an oxime and α,β-unsaturated ketone. 
 
 As a class of molecules, α,β-unsaturated nitrones are not well known in comparison to 
nitrones overall. Although there are several methods available to access different 
nitrones, as a subset α,β-unsaturated nitrones have received little attention. An excellent 
method, and one used to synthesize nitrones for use in our indolenine synthesis reaction 
(vide infra), is that developed by Bartoli et al. This method
25
 allows one to make α,β-
unsaturated N-aryl ketonitrones by treating nitroarenes with crotylmagnesium chloride. 
While this method offers access to a nitrones containing functionalized aryl groups in 
one step from commercially available materials, the researcher is limited by the Grignard 
reagent; few crotyl Grignard reagents are commercially available. In addition, 








DIASTEREOSELECTIVE SYNTHESIS OF C-3 QUATERNARY INDOLENINES 




 Our group, in the course of conducting another study, discovered that C3-quaternary 
indolenines are produced by the reaction between α,β-unsaturated ketonitrones and 
activated alkynes. This avenue of research was pursued as it promised to provide a better 
solution for an important problem. The substituted C3-quaternary indole core is a 
common core structural motif in a large number of natural products. To date, few 
methods have been developed to prepare indolenines.
27
 In contrast to this, a wide variety 
of methods to produce indoles are known.
28,29
 
 Some examples of indole containing alkaloids are shown below in Figure 2. Many of 
these compounds exhibit promising bioactivity. Communesin B, for example, has shown 
an ED50 value of 0.45 μg/mL in preliminary inihibition studies against murine lyphocytic 
leukemia cell line P-388.
30
 A C3-quaternary indolenine could serve as a convenient 
starting point for further substitution of the five-membered ring, allowing access to the 
heavily substituted indole cores seen in these natural products. A facile preparation of a 
versatile precursor to these natural products, the indolenine, opens up a new avenue of 





Figure 2. Examples of natural products containing highly substituted indole cores. 
 
 One of the research group’s projects was a γ-oxygenation of α,β-unsaturated esters via 
a vinylogous O-nitroso Mukaiyama Aldol reaction.
31
 Scheme 8 below shows this 
reaction, which was found to produce predominantly the α,β-unsaturated ketonitrone 
when carried out in methanol with acetic acid as an additive.   
 
 






 The nitrone 1,3-dipolar cycloaddition has been known for quite a long time and is well 
studied.
32
 However, during our study
33
 of the reaction of α,β-unsaturated ketonitrones 
and activated alkynes, the actual product obtained was very much different from what 
was expected. It was determined that a C3-quaternary indolenine was created after 
characterizing the product through 1 and 2-D NMR studies as well as x-ray 
crystallography. Furthermore, it was apparent that the stereoisomer isolated was the 
major product by a large margin if not the only isomer produced in the reaction. This 
initial reaction is shown below in Scheme 9. 
 
 
Scheme 9. Synthesis of C3-quaternary indolenine 2a from α,β-unsaturated N-aryl 
ketonitrone 1a and diethyl acetylenedicarboxylate. 
 
2.2 Results and Discussion 
 As this reaction displayed promise in the synthesis of indolenine precursors to indole-






Table 1. Optimization of C3-quaternary indolenine 2a reaction conditions.  
Entry Solvent T Additive Yield 
1 CH2Cl2 RT - 64 
2 THF RT - 48 
3 Ether RT - 21 
4 DMF RT - Trace 
5 iPrOH RT - Trace 
6 Toluene RT - 68 
7 Toluene RT HOAc 7 
8 Toluene RT HOAc/H2O 45 
9 Toluene RT TFA Trace 
10 Toluene RT TfOH 15 
11 Toluene RT ZnCl2 Trace 
12 Toluene RT SnCl4 Trace 
13 Toluene RT FeCl3 Trace 
14 Toluene RT TiCl4 Trace 
15 Toluene 40 - 73 
16 Toluene 80 - 79 
 
 All of the reactions were carried out with 1 equiv of 1a, 3 equiv of diethyl 
acetylenedicarboxylate, and 1.2 equiv of any additive if noted (0.2 equiv if HOAc). 
Using toluene as the solvent fared the best at room temperature (68% yield). 
Dichloromethane also proved to be an acceptable solvent giving 2a in 64% yield. It was 




reaction still progressed in ethereal solvents albeit with significantly decreased yield 
(entries 2 and 3). No significant quantity of product was observed in either DMF or 
isopropanol. Adding glacial acetic acid (entry 7) dramatically reduced the yield of 2a to 
7% while adding aqueous acetic acid (entry 8) only caused a drop to 45% yield. In both 
cases 0.2 equivalents of acetic acid were used, so the drastic difference between the two 
must be attributable to the addition of water. Though it is difficult to speculate this could 
be perhaps be due to the creation of a biphasic system, greatly reducing the amount of 
acetic acid available to interact with the reactants in the toluene phase. Conducting the 
reaction at a higher temperature (entries 15 and 16) in toluene also offered slightly 
improved yield; unless otherwise noted all subsequent reactions were conducted under 





Scheme 10. Reaction of ketonitrones 1 with activated alkynes. 
 
 After optimizing the reaction, we then explored the scope of substrates (Scheme 10). 
The ketonitrone ester R-group was varied, and it was found that the tert-butyl ester 
provided a greater yield than the less bulky ethyl and methyl esters (2a vs. 2b and 2c). A 
variety of alkynes were tested. Unactivated alkynes, including phenylacetylene, 
diphenylacetylene and 6-dodecyne did not undergo the reaction at all. All other alkynes 




initially. Monoactivated alkynes were found to undergo the reaction in moderate yields. 
Alkyl propiolates 2h-2j display a strong trend of decreasing yield with increased steric 
bulk on the ester group; substituting a methyl group for a tert-butyl effectively cut the 
yield in half. Interestingly, this effect of steric bulk on the ester group of the activated 
alkyne is very much the opposite of that seen with the ketonitrone ester group. However, 
in an alkyne (2e) in which an alkyl group opposite the ester was increased in size as 
well, a less drastic drop in yield was observed (from 2d). This implies the increased 
steric bulk on the alkyne opposite the ester increases the reactivity of the alkyne. The 
same regioselectivity was still present with all substrates, and the reaction produced 
apparently only the anti- diastereomer. No isolable quantity of the other diastereomers 
was produced. 
 Next, in order to test the generality of the reaction with respect to the nitrone, we 
attempted to perform this reaction using N-aryl ketonitrones with a terminal alkene 
rather than the β-ester substituent (Scheme 11). We made these with the aforementioned 
convenient method developed by Bartoli
25
 and coworkers in which nitrones are 







Scheme 11. Reaction of ketonitrones 3 with activated alkynes. (a) These reactions were 
conducted at RT. 
 
 Nitrone group 3 reacted with diethyl acetylene dicarboxylate to form indolenine 4 in 
yields very much comparable to the nitrones tested previously. We varied the 
functionality on the aromatic ring to determine if it would have significantly impact the 
yield as well as assess the selectivity of the reaction with regard to substitutions on the 




substitutions did not exhibit any unexpected effects and formed 5- and 7-methyl 
indolenines respectively. Although these substitutions generally resulted in yields of 
indolenine comparable to those lacking such substitutions, manipulating the identity of 
the substituent had quite a large impact on the reaction with yields ranging from 78% to 
22% on otherwise similar substrate (4g versus 4f). A wide variety of substituents were 
found to participate in the reaction, including alkoxy groups (4l-4o), methyl groups (4b, 
4g and 4i), halides at 3’ and 5’ positions (4c 4h and 4j), and an amine (4e). The least 
effective substrate was the N-phenyl ketonitrone containing a cyano group yielding 
indolenine 4f with a cyano group at the para position. A quick test indicated that an 
indolenine (4p) is still produced when the only activating group on the alkyne is a ketone 
rather than an ester as used in all other examples. 
2.3 Experimental 
2.3.1 Synthetic Considerations 
General experimental concerns 
 All non-aqueous reactions were carried out in flame-dried glassware under a N2 
atmosphere. Dichloromethane and diethyl ether were purified by passage through an 
activated molecular sieve solvent purification system. Tetrahydrofuran was freshly 
distilled over sodium and benzophenone. All other commercial reagents were used as 
received. 
1H NMR chemical shifts are reported as δ values in ppm relative to CDCl3 
(7.26 ppm) or CD3OD (4.57 ppm), coupling constants (J) are reported in Hertz (Hz), and 
multiplicity follows convention. Deuterochloroform (CDCl3, 77.16 ppm) served as the 
internal standard for 
13




using 60Å silica gel (Silicycle, 230-400 mesh) as the stationary phase. Mass spectra 
were obtained at the Center for Chemical Characterization and Analysis (Texas A&M 
University). Thin layer chromatography (TLC) was performed using pre-coated glass-
backed TLC plates, Silica Gel 60 F254 (EMD, 250 μm thickness). 
Synthesis of α,β-unsaturated N-aryl ketonitrones 
 The α,β-Unsaturated N-phenyl ketonitrones 1 were synthesized according to the 
procedure we previously described.
31
 A solution of nitrosobenzene (51s mg, 0.48 mmol) 
in methanol (1 mL) was treated with acetic acid (14 mL, 0.24 mmol) and (((1Z,3Z)-1 
(tert-butoxy)penta-1,3-dien-1-yl)oxy)(tert-butyl)dimethylsilane (54 mg, 0.20 mmol) at 
-78 °C. The reaction mixture was slowly allowed to room temperature over 2 h. The 
solvent was removed under vacuum and the residue was directly loaded onto a silica gel 
column for flash chromatography (petroleum ether/ethyl acetate ~ 2:1) to obtain 3 (33 
mg, 64%). 
1
H NMR (CDCl3, 300 MHz): δ 1.45 (s, 9H), 2.42 (s, 3H), 6.04 (d, J = 15.3 
Hz, 1H), 7.24 (d, J = 15.3 Hz, 1H), 7.29-7.37 (m, 2H), 7.48-7.50 (m, 3H); 
13
C NMR 
(CDCl3, 75 MHz): δ 13.3, 28.0, 81.1, 122.7, 124.3, 129.5, 130.0, 134.3, 145.4, 146.0, 
165.2; HRMS (ESI) calcd for C15H20NO3 (M+H)
+
 262.1443, found 262.1437. 
A general procedure for synthesis of α,β-unsaturated N-aryl ketonitrones 3 
 A solution of the nitroarene (0.16 M, 1 equiv.) in anhydrous THF was cooled to -78 
o
C 
and treated with a solution of crotylmagnesium chloride (1.6 M in THF, 1.1 equiv.) 
dropwise. The mixture was stirred at the same temperature for 15 min before the reaction 
was quenched with aq. NH4Cl and extracted with diethyl ether (3x). The organic phase 




pressure. The crude was purified by silica gel column chromatography (eluted with 
100% ethyl acetate or 5% methanol in CH2Cl2) to give 3. 
A representative procedure for the synthesis of the C3-quaternary indolenines 
 A solution of the α,β-unsaturated N-aryl ketonitrone (0.2 M, 1 equiv.) and the 
activated alkyne (3 equiv.) in toluene was stirred at 80 
o
C until TLC indicated the 
reaction was complete. The homogenous solution was concentrated in vacuo and the 
residue was purified by silica gel column chromatography, eluted with hexanes–ethyl 
acetate, to give the C3-quaternary indolenines. 
2.3.2 Spectral Data for New Compounds 
Diethyl 3-(1-(tert-butoxy)-1,4-dioxopentan-2-yl)-3H-indole-2,3-dicarboxylate (2a) 
 Prepared according to the general procedure in 79% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.80 (d, J = 7.7 Hz, 1H), 7.54 – 7.35 (m, 3H), 4.58 – 4.36 (m, 2H), 4.23 (dd, J 
= 11.0, 2.6 Hz, 1H), 4.12 (dq, J = 10.8, 7.1 Hz, 1H), 3.95 (dq, J = 10.8, 7.1 Hz, 1H), 3.36 
(dd, J = 17.5, 2.5 Hz, 1H), 3.13 (dd, J = 17.5, 11.0 Hz, 1H), 2.18 (s, 3H), 1.45 (t, J = 7.1 
Hz, 3H), 1.21 (s, 9H), 1.06 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 206.0, 
169.6, 169.5, 167.9, 161.4, 154.5, 137.0, 130.0, 128.7, 123.9, 123.9, 82.3, 66.8, 62.4, 
62.2, 44.0, 41.8, 30.1, 27.6, 14.4, 13.9. HRMS (ESI, m/z): [M]
+
 calc.: 432.1083; found: 
432.1090. 
Diethyl 3-(1-methoxy-1,4-dioxopentan-2-yl)-3H-indole-2,3-dicarboxylate (2b) 
 Prepared according to the general procedure in 58% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.78 (d, J = 7.7 Hz, 1H), 7.55 – 7.35 (m, 3H), 4.46 (qd, J = 7.1, 1.7 Hz, 2H), 




11.0 Hz, 1H), 2.73 (dd, J = 17.5, 2.5 Hz, 1H), 2.10 (s, 3H), 1.43 (t, J = 7.1 Hz, 3H), 1.10 
(t, J = 7.1 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 205.8, 171.1, 169.2, 167.7, 161.6, 
153.9, 136.8, 130.2, 129.0, 123.9, 123.8, 67.0, 62.5, 62.4, 52.4, 43.6, 40.8, 30.1, 14.3, 
13.8. HRMS (ESI, m/z): [M]
+
 calc.: 390.1553; found: 390.1562. 
Diethyl 3-(1-ethoxy-1,4-dioxopentan-2-yl)-3H-indole-2,3-dicarboxylate (2c) 
 Prepared according to the general procedure in 61% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.79 (d, J = 7.6 Hz, 1H), 7.57 – 7.38 (m, 3H), 4.53 – 4.40 (m, 2H), 4.33 (dd, J 
= 10.8, 2.6 Hz, 1H), 4.23 – 4.07 (m, 2H), 4.07 – 3.89 (m, 2H), 3.05 (dd, J = 17.4, 10.8 
Hz, 1H), 2.83 (dd, J = 17.5, 2.6 Hz, 1H), 2.12 (s, 3H), 1.45 (t, J = 7.1 Hz, 3H), 1.12 (dt, 
J = 8.4, 7.1 Hz, 6H); 
13
C NMR (75 MHz, CDCl3) δ 205.9, 170.6, 169.3, 167.8, 161.6, 
154.1, 136.9, 130.2, 129.0, 124.0, 123.9, 67.1, 62.5, 62.3, 61.6, 43.64, 40.9, 30.1, 14.4, 
13.9. HRMS (ESI, m/z): [M]
+
 calc.: 404.1709; found: 404.1719. 
Dimethyl 3-(1-ethoxy-1,4-dioxopentan-2-yl)-3H-indole-2,3-dicarboxylate (2d)
 Prepared according to the general procedure in 57% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.78 (d, J = 7.0 Hz, 1H), 7.56 – 7.37 (m, 3H), 4.32 (dd, J = 10.9, 2.6 Hz, 1H), 
4.00 (s, 3H), 3.62 (s, 3H), 3.03 (dd, J = 17.4, 11.0 Hz, 1H), 2.73 (dd, J = 17.4, 2.5 Hz, 
1H), 2.12 (s, 3H), 1.14 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 205.7, 170.5, 
168.7, 168.2, 161.9, 153.8, 136.7, 130.3, 129.2, 124.0, 123.9, 67.0, 61.6, 53.2, 53.2, 
43.6, 40.6, 30.1, 13.8. HRMS (ESI, m/z): [M]
+
 calc.: 376.1396; found: 376.1407. 
Di-tert-butyl 3-(1-ethoxy-1,4-dioxopentan-2-yl)-3H-indole-2,3-dicarboxylate (2e) 
 Prepared according to the general procedure in 42% yield. 
1
H NMR (300 MHz, 




1H), 4.00 – 3.78 (m, 2H), 3.33 (dd, J = 17.6, 2.5 Hz, 1H), 3.12 (dd, J = 17.6, 11.0 Hz, 
1H), 2.15 (s, 3H), 1.63 (s, 9H), 1.23 (s, 9H), 1.09 (t, J = 7.2 Hz, 3H); 
13
C NMR (75 δ 
7.77 (m, 1H), 7.55-7.35 (m, 3MHz, CDCl3) δ 206.1, 170.9, 170.7, 166.7, 160.1, 154.7, 
137.2, 129.7, 128.3, 123.8, 123.4, 83.7, 82.8, 67.3, 61.4, 30.0, 28.1, 27.7, 13.9. HRMS 
(ESI, m/z): [M]
+
 calc.: 460.2335; found: 460.2328. 
Diethyl 3-(1-ethoxy-1,4-dioxoundecan-2-yl)-3H-indole-2,3-dicarboxylate (2f) 
 Prepared according to the general procedure in 70% yield. 
1
H NMR (300MHz, CDCl3) 
H), 4.55-3.90 (m, 7H), 3.00 (dd, J = 17.1, 10.5 Hz, 1H), 2.75 (dd, J = 17.4, 2.7 Hz, 1H), 
2.35 (m, 2H), 1.44 (t, J = 7.2 Hz, 3H), 1.35-1.17 (m, 10H), 1.13 (t, J = 6.9 Hz, 3H), 1.10 
(t, J = 7.2 Hz, 3H), 0.85 (t, J = 6.9 Hz, 3H); 
13
C NMR (75MHz, CDCl3) δ 208.5, 170.9, 
169.6, 168.0, 161.8, 154.2, 137.1, 130.3, 129.2, 124.1, 102.8 67.4, 62.7, 62.5, 61.8, 43.7, 
43.1, 40.2, 32.0, 29.4, 29.3, 23.9, 22.9, 14.5, 14.4, 14.3, 14.0. HRMS (ESI, m/z): 
[M+H]
+
 calc.: 460.2335; found: 460.2328. 
Diethyl 3-(1-ethoxy-1,4-dioxo-6-phenylhexan-2-yl)-3H-indole-2,3-dicarboxylate (2g) 
 Prepared according to the general procedure in 61% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.81 – 7.75 (m, 1H), 7.52 – 7.34 (m, 3H), 7.29 – 7.10 (m, 5H), 4.53 – 4.40 (m, 
2H), 4.36 (dd, J = 10.8, 2.7 Hz, 1H), 4.19 – 4.06 (m, 2H), 4.06 – 3.90 (m, 2H), 3.02 (dd, 
J = 17.3, 10.8 Hz, 1H), 2.88 – 2.76 (m, 2H), 2.76 – 2.64 (m, 2H), 1.45 (t, J = 7.1 Hz, 
3H), 1.12 (dt, J = 7.7, 7.2 Hz, 6H); 
13
C NMR (75 MHz, CDCl3) δ 207.1, 170.6, 169.3, 
167.7, 161.6, 154.0, 141.0, 136.9, 130.2, 129.0, 128.6, 128.6, 128.4, 126.2, 123.9, 123.9, 
67.2, 62.5, 62.3, 61.6, 44.5, 43.6, 40.1, 29.6, 14.4, 13.9. HRMS (ESI, m/z): [M]
+
 calc.: 




Methyl 3-(1-(tert-butoxy)-1,4-dioxopentan-2-yl)-3H-indole-3-carboxylate (2h) 
 Prepared according to the general procedure in 61% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 8.30 (s, 1H), 7.64 (d, J = 7.7 Hz, 1H), 7.42 (t, J = 7.7 Hz, 2H), 7.28 (t, J = 7.5 
Hz, 1H), 4.11 (dd, J = 8.3, 4.4 Hz, 1H), 3.68 (s, 3H), 2.35 (dd, J = 17.6, 8.3 Hz, 1H), 
1.83 (s, 3H), 1.67 (dd, J = 17.6, 4.4 Hz, 1H), 1.47 (s, 9H); 
13
C NMR (75 MHz, CDCl3) δ 
205.3, 171.2, 171.1, 169.6, 155.4, 134.5, 129.9, 127.3, 123.7, 121.6, 82.7, 67.9, 53.1, 
44.8, 39.5, 30.0, 28.0. HRMS (ESI, m/z): [M]
+
 calc.: 346.1654; found: 346.1641. 
Ethyl 3-(1-(tert-butoxy)-1,4-dioxopentan-2-yl)-3H-indole-3-carboxylate (2i) 
 Prepared according to the general procedure in 45% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 8.31 (s, 1H), 7.62 (d, J = 7.6 Hz, 1H), 7.47 – 7.36 (m, 2H), 7.31 – 7.22 (m, 
1H), 4.21 – 4.02 (m, 3H), 2.34 (dd, J = 17.5, 8.4 Hz, 1H), 1.83 (s, 3H), 1.67 (dd, J = 
17.6, 4.4 Hz, 1H), 1.46 (s, 9H), 1.18 (t, J = 7.1 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 
205.3, 171.4, 171.1, 168.9, 155.4, 134.6, 129.8, 127.2, 123.6, 121.6, 82.6, 68.0, 62.2, 
44.7, 39.6, 30.0, 28.0, 14.0. HRMS (ESI, m/z): [M]
+
 calc.: 360.1811; found: 360.1802. 
tert-Butyl 3-(1-(tert-butoxy)-1,4-dioxopentan-2-yl)-3H-indole-3-carboxylate (2j) 
 Prepared according to the general procedure in 32% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 8.34 (s, 1H), 7.61 (d, J = 7.2 Hz, 1H), 7.44 – 7.35 (m, 2H), 7.30 – 7.21 (m, 
1H), 4.02 (dd, J = 8.3, 4.5 Hz, 1H), 2.32 (dd, J = 17.3, 8.3 Hz, 1H), 1.83 (s, 3H), 1.72 
(dd, J = 17.4, 4.5 Hz, 1H), 1.45 (s, 9H), 1.35 (s, 9H); 
13
C NMR (75 MHz, CDCl3) δ 
205.2, 172.0, 171.4, 167.7, 155.6, 135.0, 129.6, 127.0, 123.4, 121.5, 83.1, 82.5, 69.1, 
44.8, 40.1, 30.0, 28.1, 27.9. HRMS (ESI, m/z): [M]
+






 Prepared according to the general procedure in 37% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 8.14 – 8.06 (m, 2H), 7.68 (d, J = 7.6 Hz, 1H), 7.51 – 7.40 (m, 5H), 7.31 – 7.23 
(m, 1H), 4.17 – 3.89 (m, 3H), 3.34 (dd, J = 17.5, 3.1 Hz, 1H), 3.16 (dd, J = 17.5, 10.3 
Hz, 1H), 2.19 (s, 3H), 1.01 – 0.92 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 206.3, 170.2, 
169.2, 155.9, 137.6, 133.2, 131.0, 130.3, 129.7, 128.7, 128.6, 126.1, 123.3, 121.5, 81.6, 
67.1, 62.2, 44.8, 42.3, 30.1, 27.3, 13.8. HRMS (MALDI, m/z): [M]
+
 calc.: 436.2118; 
found: 436.2112. 
(E)-N-(But-3-en-2-ylidene)aniline oxide (3a) 
 Prepared according to the general procedure in 86% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.52 – 7.40 (m, 3H), 7.36 – 7.28 (m, 2H), 6.33 (dd, J = 17.1, 11.1 Hz, 1H), 
5.51 (d, J = 17.1 Hz, 1H), 5.23 (d, J = 11.1 Hz, 1H), 2.40 (s, 3H); 
13
C NMR (75 MHz, 
CDCl3) δ 129.9, 129.6, 129.5, 124.4, 123.6, 118.5, 12.8. HRMS (ESI, m/z): [M]
+
 calc.: 
162.0919; found: 162.0914. 
(E)-N-(But-3-en-2-ylidene)-4-methylaniline oxide (3b)  
 Prepared according to the general procedure in 45% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.27 – 7.17 (m, 4H), 6.36 (dd, J = 17.1, 11.1 Hz, 1H), 5.49 (d, J = 17.2 Hz, 
1H), 5.21 (d, J = 11.2 Hz, 1H), 2.39 (s, 3H), 2.38 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 
139.6, 130.0, 130.0, 124.2, 123.4, 118.1, 21.3, 12.8. HRMS (ESI, m/z): [M]
+
 calc.: 





(E)-N-(But-3-en-2-ylidene)-4-chloroaniline oxide (3c) 
 Prepared according to the general procedure in 78% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.43 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 8.4 Hz, 2H), 6.33 (dd, J = 17.1, 11.1 Hz, 
1H), 5.54 (d, J = 17.1 Hz, 1H), 5.27 (d, J = 11.1 Hz, 1H), 2.39 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 135.4, 129.7, 129.5, 125.8, 125.1, 119.1, 12.8. HRMS (ESI, m/z): [M]
+
 
calc.: 196.0529; found: 196.0537. 
(E)-N-(But-3-en-2-ylidene)-4-methoxyaniline oxide (3d)   
 Prepared according to the general procedure in 65% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.27 (d, J = 8.9 Hz, 2H), 6.93 (d, J = 9.0 Hz, 2H), 6.38 (dd, J = 17.2, 11.1 Hz, 
1H), 5.49 (d, J = 17.1 Hz, 1H), 5.22 (d, J = 11.1 Hz, 1H), 3.83 (s, 3H), 2.38 (s, 3H); 
13
C 
NMR (75 MHz, CDCl3) δ 130.1, 125.7, 118.1, 114.5, 55.7, 12.9. HRMS (ESI, m/z): 
[M]
+
 calc.: 192.1025; found: 192.1028. 
(E)-N-(But-3-en-2-ylidene)-4-(dimethylamino)aniline oxide (3e) 
 Prepared according to the general procedure in 56% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.20 (d, J = 9.1 Hz, 2H), 6.67 (d, J = 9.1 Hz, 2H), 6.46 (dd, J = 17.2, 11.1 Hz, 
1H), 5.45 (d, J = 17.2 Hz, 1H), 5.18 (d, J = 11.1 Hz, 1H), 2.99 (s, 6H), 2.37 (s, 3H); 
13
C 
NMR (75 MHz, CDCl3) δ 130.6, 125.3, 117.3, 111.8, 40.6, 13.1. HRMS (ESI, m/z): 
[M]+ calc.: 205.1341; found: 205.1333. 
(E)-N-(But-3-en-2-ylidene)-4-cyanoaniline oxide (3f) 
 Prepared according to the general procedure in 20% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.72 (d, J = 8.6 Hz, 2H), 7.41 (d, J = 8.5 Hz, 2H), 6.20 (dd, J = 17.0, 11.1 Hz, 
1H), 5.56 (d, J = 17.0 Hz, 1H), 5.29 (d, J = 11.1 Hz, 1H), 2.35 (s, 3H); 
13




MHz, CDCl3) δ 133.53, 128.68, 125.36, 120.23, 117.49, 113.46, 12.68. HRMS (ESI, 
m/z): [M]
+
 calc.: 187.0871; found: 187.0876.  
(E)-N-(But-3-en-2-ylidene)-2-methylaniline oxide (3g) 
 Prepared according to the general procedure in 70% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.37 – 7.15 (m, 4H), 6.15 (dd, J = 17.1, 11.1 Hz, 1H), 5.52 (d, J = 17.1 Hz, 
1H), 5.22 (d, J = 11.1 Hz, 1H), 2.41 (s, 3H), 2.21 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 
131.9, 131.5, 129.4, 129.2, 127.2, 124.2, 118.8, 16.7, 12.1. HRMS (ESI, m/z): [M]
+
 
calc.: 176.1075; found: 176.1071. 
(E)-2-Bromo-N-(but-3-en-2-ylidene)aniline oxide (3h) 
 Prepared according to the general procedure in 67% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.65 (dd, J = 8.0, 1.3 Hz, 1H), 7.46 – 7.27 (m, 3H), 6.11 (dd, J = 17.0, 11.1 
Hz, 1H), 5.57 (d, J = 17.0 Hz, 1H), 5.28 (d, J = 11.1 Hz, 1H), 2.41 (s, 3H); 
13
C NMR (75 
MHz, CDCl3) δ 133.9, 130.6, 128.9, 128.8, 126.1, 119.6, 117.5, 12.1. HRMS (ESI, m/z): 
[M]
+
 calc.: 240.0024; found: 240.0021. 
(E)-N-(But-3-en-2-ylidene)-3-methylaniline oxide (3i) 
 Prepared according to the general procedure in 70% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.38 – 7.07 (m, 3H), 6.35 (dd, J = 17.0, 11.2 Hz, 1H), 5.50 (d, J = 17.1 Hz, 
1H), 5.23 (d, J = 11.1 Hz, 1H), 2.39 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 130.2, 130.0, 
129.3, 124.9, 121.4, 118.3, 21.4, 12.7. HRMS (ESI, m/z): [M]
+







(E)-N-(But-3-en-2-ylidene)-3-chloroaniline oxide (3j) 
 Prepared according to the general procedure in 48% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.44 – 7.34 (m, 3H), 7.24 – 7.19 (m,1H), 6.31 (dd, J = 17.1, 11.1 Hz, 1H), 5.54 
(d, J = 17.1 Hz, 1H), 5.28 (d, J = 11.1 Hz, 1H), 2.38 (s, 3H); 
13
C NMR (75 MHz, CDCl
3
) 
δ 130.6, 129.8, 129.4, 124.9, 122.6, 119.3, 12.8. HRMS (ESI, m/z): [M]+ calc.: 
196.0529; found: 196.0532.  
(E)-N-(But-3-en-2-ylidene)-2,4-dimethoxyaniline oxide (3k) 
 Prepared according to the general procedure in 71% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.18 (d, J = 9.5 Hz, 1H), 6.56 – 6.48 (m, 2H), 6.23 (dd, J = 17.2, 11.1 Hz, 1H), 
5.48 (d, J = 17.1 Hz, 1H), 5.20 (d, J = 11.2 Hz, 1H), 3.83 (s, 3H), 3.80 (s, 3H), 2.38 (s, 
3H); 
13
C NMR (75 MHz, CDCl3) δ 161.4, 153.0, 129.9, 126.4, 118.2, 104.8, 99.7, 56.1, 
55.8, 12.4. HRMS (ESI, m/z): [M]
+
 calc.: 222.1130; found: 222.1132. 
Diethyl 3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (4a) 
 Prepared according to the general procedure in 70% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.81 (d, J = 7.6 Hz, 1H), 7.50 – 7.36 (m, 3H), 4.44 (qd, J = 14.2, 7.1, 1.8 Hz, 
2H), 4.14 (ddd, J = 17.9, 9.0, 5.3 Hz, 1H), 3.95 (dq, J = 14.2, 10.8, 7.1 Hz, 1H), 2.90 – 
2.67 (m, 2H), 1.86 (s, 3H), 1.97 – 1.64 (m, 2H), 1.42 (t, J = 7.1 Hz, 3H), 1.07 (t, J = 7.1 
Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 206.7, 170.0, 168.7, 161.4, 154.0, 138.5, 129.8, 
129.2, 123.7, 122.7, 66.6, 62.4, 62.0, 37.1, 29.9, 27.0, 14.3, 13.9. HRMS (ESI, m/z): 
[M]
+






Diethyl 5-methyl-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (4b) 
 Prepared according to the general procedure in 52% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.69 (d, J = 7.9 Hz, 1H), 7.30 – 7.16 (m, 2H), 4.44 (qd, J = 7.1, 2.2 Hz, 2H), 
4.17 (dq, J = 10.8, 7.1 Hz, 1H), 3.95 (dq, J = 10.7, 7.1 Hz, 1H), 2.90 – 2.65 (m, 2H), 
2.42 (s, 3H), 1.97 – 1.83 (m, 1H), 1.89 (s, 3H), 1.78 – 1.67 (m, 1H), 1.42 (t, J = 7.1Hz, 
3H), 1.09 (t, J = 7.1 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 206.9, 169.0, 169.0, 161.6, 
151.9, 139.9, 138.7, 130.6, 123.4, 123.3, 66.3, 62.3, 62.0, 37.2, 30.0, 27.1, 21.9, 14.4, 
14.0. HRMS (ESI, m/z): [M]
+ 
calc.: 346.1655; found: 346.1653. 
Diethyl 5-chloro-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (4c) 
 Prepared according to the general procedure in 57% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.74 (d, J = 8.3 Hz, 1H), 7.49 – 7.37 (m, 2H), 4.45 (dq, J = 14.2, 7.1, 1.6 Hz, 
2H), 4.18 (dq, J = 14.2, 10.8, 7.1 Hz, 1H), 3.98 (dq, J = 14.1, 10.6, 7.0 Hz, 1H), 2.92 – 
2.63 (m, 2H), 1.92 (s, 3H), 1.98 – 1.77 (m, 2H), 1.42 (t, J = 7.1 Hz, 3H), 1.11 (t, J = 7.1 
Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 206.4, 168.1, 161.2, 152.5, 140.2, 135.4, 130.2, 
124.6, 123.3, 66.9, 62.6, 62.4, 37.1, 29.9, 27.1, 14.3, 13.9. HRMS (ESI, m/z): [M]
+
 calc.: 
366.1108; found: 366.1097. 
Diethyl 5-methoxy-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate dicarboxylate (4d) 
 Prepared according to the general procedure in 52% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.72 (d, J = 8.5 Hz, 1H), 7.00 – 6.89 (m, 2H), 4.43 (dq, J = 7.1, 2.3 Hz, 2H), 
4.17 (dq, J = 10.8, 7.1 Hz, 1H), 3.96 (dq, J = 10.7, 7.1 Hz, 1H), 3.84 (s, 3H), 2.84 (ddd, J 
= 14.2, 9.7, 6.1 Hz, 1H), 2.75 – 2.63 (m, 1H), 1.97 – 1.84 (m, 1H), 1.89 (s, 3H), 1.72 






NMR (75 MHz, CDCl3) δ 206.8, 168.9, 167.6, 161.5, 161.1, 147.5, 140.6, 124.6, 115.4, 
108.3, 66.5, 62.2, 62.1, 56.0, 37.1, 30.0, 27.3, 14.4, 14.0. HRMS (ESI, m/z): [M]
+
 calc.: 
362.1604; found: 362.1607. 
Diethyl 5-(dimethylamino)-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (4e) 
 Prepared according to the general procedure in 53% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.65 (d, J = 8.7 Hz, 1H), 6.71 (dd, J = 8.7, 2.6 Hz, 1H), 6.65 (d, J = 2.5 Hz, 
1H), 4.42 (qd, J = 7.1, 2.7 Hz, 2H), 4.19 (dq, J = 14.2, 10.8, 7.1 Hz, 1H), 3.94 (dq, J = 
10.8, 7.1 Hz, 1H), 3.04 (s, 6H), 2.83 (ddd, J = 14.1, 10.3, 5.8 Hz, 1H), 2.75 – 2.61 (m, 
1H), 2.02 – 1.85 (m, 1H), 1.90 (s, 3H), 1.77 – 1.62 (m, 1H), 1.41 (t, J = 7.1 Hz, 3H), 
1.10 (t, J = 7.1 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 207.2, 169.6, 164.0, 161.7, 151.4, 
143.8, 141.1, 124.4, 112.4, 105.5, 65.9, 61.8, 61.8, 40.7, 37.1, 30.0, 27.6, 14.4, 14.0. 
HRMS (ESI, m/z): [M]
+
 calc.: 375.1920; found: 375.1911. 
Diethyl 5-cyano-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (4f) 
 Prepared according to the general procedure in 22% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.92 (d, J = 8.0 Hz, 1H), 7.80 (dd, J = 8.1, 1.5 Hz, 1H), 7.71 (d, J = 0.9 Hz, 
1H), 4.49 (qd, J = 7.1, 0.9 Hz, 2H), 4.19 (dq, J = 14.2, 10.8, 7.1 Hz, 1H), 4.01 (dq, J = 
14.2, 10.8, 7.1 Hz, 1H), 2.96 – 2.83 (m, 1H), 2.80 – 2.67 (m, 1H), 1.94 (s, 3H), 1.95 – 
1.84 (m, 2H), 1.45 (t, J = 7.1 Hz, 3H), 1.12 (t, J = 7.1 Hz, 3H); HRMS (ESI, m/z): [M]
+
 
calc.: 357.1450; found: 357.1442. 
Diethyl 7-methyl-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (4g) 
 Prepared according to the general procedure in 78% yield. 
1
H NMR (300 MHz, 




1H), 3.95 (dq, J = 10.8, 7.1 Hz, 1H), 2.89 – 2.68 (m, 2H), 2.67 (s, 1H), 1.89 (s, 1H), 1.96 
– 1.82 (m, 1H), 1.79 – 1.65 (m, 1H), 1.43 (t, J = 7.1 Hz, 3H), 1.09 (t, J = 7.1 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 206.9, 169.0, 168.8, 161.6, 152.9, 138.5, 134.0, 131.2, 
129.2, 120.0, 66.7, 62.4, 62.0, 37.2, 30.0, 27.1, 17.2, 14.3, 14.0. HRMS (ESI, m/z): [M]
+
 
calc.: 346.1655; found: 346.1646. 
Diethyl 7-bromo-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (4h) 
 Prepared according to the general procedure in 74% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.62 (dd, J = 7.9, 1.1 Hz, 1H), 7.38 – 7.21 (m, 2H), 4.45 (qd, J = 7.1, 1.7 Hz, 
2H), 4.15 (dq, J = 10.8, 7.1 Hz, 1H), 3.96 (dq, J = 10.8, 7.1 Hz, 1H), 2.92 – 2.64 (m, 
2H), 2.02 – 1.85 (m, 1H), 1.90 (s, 3H), 1.71 (ddd, J = 17.9, 9.7, 5.3 Hz, 1H), 1.42 (t, J = 
7.1 Hz, 3H), 1.09 (t, J = 7.1 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 206.5, 170.9, 168.2, 
161.3, 152.6, 140.0, 133.5, 130.4, 121.7, 117.7, 68.3, 62.6, 62.4, 37.0, 30.0, 27.2, 14.3, 
13.9. HRMS (ESI, m/z): [M]
+
 calc.: 410.0603; found: 410.0609. 
Diethyl 6-methyl-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (4i) 
 Prepared according to the general procedure in 61% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.62 (s, 1H), 7.32 – 7.17 (m, 2H), 4.46 (dq, J = 7.1, 1.8 Hz, 2H), 4.15 (dq, J = 
14.2, 10.8, 7.1 Hz, 1H), 3.95 (dq, 1H), 2.88 – 2.66 (m, 2H), 2.44 (s, 3H), 1.89 (s, 3H), 
1.97 – 1.82 (m, 1H), 1.82 – 1.66 (m, 1H), 1.43 (t, J = 7.1 Hz, 3H), 1.09 (t, J = 7.1 Hz, 
3H); 
13
C NMR (75 MHz, CDCl3) δ 206.8, 170.1, 168.9, 161.4, 154.3, 140.1, 135.5, 
130.0, 124.3, 122.2, 66.2, 62.3, 61.9, 37.11, 29.9, 26.9, 21.7, 14.3, 13.9. HRMS (ESI, 
m/z): [M]
+





Diethyl 6-chloro-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (4j) 
 Prepared according to the general procedure in 33% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.80 (dd, J = 1.8, 0.5 Hz, 1H), 7.42 – 7.31 (m, 2H), 4.47 (qd, 2H), 4.16 (dq, J = 
14.2, 10.7, 7.1 Hz, 1H), 3.98 (dq, J = 10.8, 7.1 Hz, 1H), 2.92 – 2.67 (m, 2H), 1.91 (s, 
3H), 1.98 – 1.75 (m, 2H), 1.44 (t, J = 7.1, 2.5 Hz, 3H), 1.11 (t, 3H); 13C NMR (75 MHz, 
CDCl3) δ 206.31, 168.09, 161.05, 160.31, 154.98, 136.62, 135.45, 129.10, 123.90, 
123.38, 66.47, 62.50, 62.18, 36.94, 29.80, 26.73, 14.15, 13.77. HRMS (ESI, m/z): [M]
+
 
calc.: 366.1108; found: 366.1104. 
Diethyl 5,7-dimethoxy-3-(3-oxobutyl)-3H-indole-2,3-dicarboxylate (4k) 
 Prepared according to the general procedure in 52% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 6.49 (s, 6H), 4.45 – 4.32 (dq, 2H), 4.22 – 4.08 (dq, 1H), 3.96 (s, 3H), 4.01 – 
3.88 (dq, 1H), 3.83 (s, 3H), 2.82 (ddd, J = 14.3, 10.4, 5.7 Hz, 1H), 2.71 – 2.57 (m, 1H), 
1.99 – 1.83 (m, 1H), 1.90 (s, 3H), 1.75 – 1.60 (m, 1H), 1.37 (td, J = 7.1Hz, 3H), 1.07 (t, 
J = 7.1Hz, 3H). HRMS (ESI, m/z): [M]
+
 calc.: 392.1709; found: 392.1717. 
Methyl 5-methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (4l) 
 Prepared according to the general procedure in 66% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.99 (s, 1H), 7.54 (d, J = 8.5 Hz, 1H), 7.04 (d, J = 2.5 Hz, 1H), 6.92 (dd, J = 
8.5, 2.6 Hz, 1H), 3.84 (s, 3H), 3.69 (s, 3H), 2.56 (ddd, J = 14.0, 9.3, 6.1 Hz, 1H), 2.46 – 
2.32 (m, 1H), 2.21 – 2.01 (m, 2H), 1.99 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 206.8, 
170.1, 169.4, 159.3, 148.9, 137.8, 122.0, 114.3, 109.8, 66.9, 56.0, 53.1, 37.8, 30.1, 27.7. 
HRMS (ESI, m/z): [M]
+





Ethyl 5-methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (4m) 
 Prepared according to the general procedure in 52% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.99 (s, 1H), 7.51 (d, J = 8.5 Hz, 1H), 7.03 (d, J = 2.5 Hz, 1H), 6.90 (dd, J = 
8.5, 2.6 Hz, 1H), 4.25 – 4.02 (m, 2H), 3.82 (s, 3H), 2.54 (ddd, J = 14.1, 9.3, 6.1 Hz, 1H), 
2.46 – 2.29 (m, 1H), 2.14 – 2.00 (m, 2H), 1.97 (s, 3H), 1.20 (t, J = 7.1 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) δ 206.7, 169.5, 169.4, 159.1, 148.7, 137.7, 121.7, 114.1, 109.7, 
66.8, 62.0, 55.8, 37.6, 29.9, 27.6, 14.0. HRMS (ESI, m/z): [M]
+
 calc.: 290.1393; found: 
290.1397. 
Allyl 5-methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (4n) 
 Prepared according to the general procedure in 61% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 8.01 (s, 1H), 7.54 (d, J = 8.5 Hz, 1H), 7.04 (d, J = 2.5 Hz, 1H), 6.92 (dd, J = 
8.5, 2.6 Hz, 1H), 5.83 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H), 5.30 – 5.16 (m, 2H), 4.67 – 4.49 
(m, 2H), 3.84 (s, 3H), 2.58 (ddd, J = 14.1, 9.4, 6.1 Hz, 1H), 2.49 – 2.32 (m, 1H), 2.15 – 
2.01 (m, 2H), 1.98 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 206.8, 169.3, 169.2, 159.3, 
148.9, 137.7, 131.3, 122.0, 119.0, 114.4, 109.8, 66.9, 66.5, 55.9, 37.7, 30.1, 27.7. HRMS 
(ESI, m/z): [M]
+
 calc.: 302.1392; found: 302.1386. 
Benzyl 5-methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (4o) 
 Prepared according to the general procedure in 69% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 8.02 (s, 1H), 7.54 (d, J = 8.5 Hz, 1H), 7.38 – 7.29 (m, 3H), 7.27 – 7.20 (m, 
2H), 7.01 (d, J = 2.5 Hz, 1H), 6.92 (dd, J = 8.5, 2.6 Hz, 1H), 5.12 (q, J = 12.3 Hz, 2H), 
3.81 (s, 3H), 2.56 (ddd, J = 14.0, 9.4, 6.0 Hz, 1H), 2.47 – 2.31 (m, 1H), 2.12 – 1.99 (m, 
2H), 1.95 (s, 3H); 
13




128.6, 128.2, 122.0, 114.6, 109.6, 67.6, 55.9, 37.7, 30.1, 27.7. HRMS (ESI, m/z): [M]
+
 
calc.: 352.1549; found: 352.1556. 
1-(5-methoxy-3-(3-oxobutyl)-3H-indol-3-yl)octan-1-one (4p) 
 Prepared according to the general procedure in 69% yield. 
1
H NMR (300 MHz, 
CDCl3) δ 7.92 (s, 1H), 7.63 (d, J = 8.5 Hz, 1H), 6.97 (dd, J = 8.5, 2.5 Hz, 1H), 6.83 (d, J 
= 2.5 Hz, 1H), 3.83 (s, 3H), 2.64 – 2.50 (m, 1H), 2.44 – 2.30 (m, 1H), 2.06 – 1.88 (m, 
7H), 1.38 (dt, J = 14.3, 7.2 Hz, 2H), 1.30 – 0.94 (m, 8H), 0.82 (t, J = 6.9 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) δ 207.3, 203.8, 169.5, 159.5, 150.3, 138.4, 122.4, 114.7, 109.0, 
75.2, 55.9, 39.4, 37.8, 31.7, 30.1, 29.0, 28.9, 24.8, 23.7, 22.7, 14.2. HRMS (ESI, m/z): 
[M]
+
 calc.: 344.2226; found: 344.2234. 
2.3.3 Synthetic Procedures and Spectral Data for 5, 6, and 7 
Methyl 5-methoxy-2-oxo-3-(3-oxobutyl)indoline-3-carboxylate (5) 
 A mixture of 4l (210 mg, 0.76 mmol) and NaHCO3 (64 mg, 0.76 mmol) in methylene 
chloride (10 mL) was treated with mCPBA (70%, 376 mg, 1.53 mmol) and stirred at 
room temperature until the reaction was complete as shown by TLC. The mixture was 
taken into ethyl acetate and washed with aq. NaHSO3, Na2CO3, and brine. The organic 
phase was separated, dried over anhydrous MgSO4, filtered, and concentrated. The 
residue was purified by silica gel column chromatography, eluted with hexanes-ethyl 
acetate (1:3), to give 5 (148 mg, 67%) as colorless oil. 
1
H NMR (300 MHz, CDCl3) δ 
9.11 (s, 1H), 6.97 – 6.67 (m, 3H), 3.76 (s, 3H), 3.69 (s, 3H), 2.59 – 2.23 (m, 4H), 2.04 (s, 
3H); 
13




111.0, 110.6, 59.1, 55.9, 53.3, 37.81, 30.0, 28.1. HRMS (ESI, m/z): [M]
+
 calc.: 
298.1267; found: 298.1263. 
Methyl 5-methoxy-3-(3-oxobutyl)indoline-3-carboxylate (6) 
 A solution of 4l (38 mg, 0.14 mmol) and trifluoroacetic acid (27.6 μL, 41 mg, 0.36 
mmol) in dichloromethane (1.5 mL) was treated with the Hantzsch ester (35 mg, 0.14 
mmol) and stirred in the dark at room temperature overnight. After dilution with diethyl 
ether, the mixture was washed with aq. Na2CO3 and dried over anhydrous MgSO4 
before it was filtered and concentrated. The residue was purified by silica gel column 
chromatography eluting with hexanes-ethyl acetate (1:3) to give 6 (29 mg, 76%) as 
yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 6.91 (d, J = 2.5 Hz, 1H), 6.68 (dd, J = 8.5, 2.5 
Hz, 1H), 6.60 (d, J = 8.5 Hz, 1H), 4.08 (d, J = 9.9 Hz, 1H), 3.75 (s, 3H), 3.72 (s, 3H), 
3.37 (d, J = 9.9 Hz, 1H), 2.53 – 2.18 (m, 4H), 2.10 (s, 3H); 13C NMR (75 MHz, CDCl3) 
δ 207.8, 174.1, 153.8, 144.7, 131.1, 114.5, 111.5, 111.2, 56.2, 56.1, 55.2, 52.6, 39.1, 
31.6, 30.1. HRMS (ESI, m/z): [M]
+
 calc.: 278.1392; found: 278.1384. 
Ethyl 5-methoxy-1H-indole-3-carboxylate (7) 
 A solution of 4m (50 mg, 0.17 mmol) in toluene (1 mL) was treated with pyrrolidine 
(28.9 mL, 24.4 mg, 0.34 mmol) and stirred at room temperature until the reaction was 
complete as shown by TLC. The residue was purified by silica gel column 
chromatography eluting with hexanes-ethyl acetate (1:3) to give 7 (38.3 mg, 
quantitative). 
1
H NMR (300 MHz, CDCl3) δ 8.81 (bs, 1H), 7.86 (d, J = 3.1 Hz, 1H), 7.68 




Hz, 2H), 3.88 (s, 3H), 1.42 (t, J = 7.1 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 165.6, 










 Considering the starting materials, the indolenine synthesis described in the previous 
chapter builds considerable complexity with a high degree of selectivity in a single step. 
However, the ultimate utility of the reaction was limited somewhat by the difficulty in 
accessing the nitrones. The nitrones were synthesized using methods that ranged from 
inefficient with regard to steps or yield or both to unsuccessful outright. Furthermore, it 
was difficult to ascertain the purity and stability of the nitrone even after multiple 
purifications. This issue was partly alleviated by application of the Bartoli method as 
described above,
25
 which provided straightforward access to nitrones with varying 
substitutions on the phenyl ring. Unfortunately, this reaction would not work with more 
complex crotyl Grignard reagents.  It became clear that it was necessary to develop a 
more streamlined approach
34
 to this class of nitrone to expand the scope of our study. 
3.2 Synthetic Strategy Development 
 In designing our own approach to α,β-unsaturated N-aryl ketonitrones, we decided that 
the oxidation of secondary amines to the nitrones would be effective and general with 
regard to the substrate. Accessing the secondary amines required for our study, from 
commercially available materials, would be facile (Scheme 12). Thus, a straightforward 




the amine could be obtained from the alkylation of an imine, specifically an aldimine. 
The aldimine could, in turn, be accessed easily from a dehydration reaction between an 
aniline derivative and an α,β-unsaturated aldehyde. A wide variety of both starting 
materials was readily available, so for all substrates the imine synthesis would be the 
synthetic starting point. 
 
 
Scheme 12. Retrosynthetic analysis from Nitrone. 
 
 After examining the literature, a relevant oxidation method developed by Busqué and 
Figueredo
35
 was found. It has been reported that Oxone® can be utilized to oxidize 
secondary amines to nitrones in good yield. Oxone®, or potassium peroxymonosulfate, 
is a commercially available oxidant that is both inexpensive and relatively stable.  Many 
similar procedures use hydrogen peroxide as the oxidant and rely on metal catalysts such 
as selenium (IV) oxide
18
 or  sodium tungstate,
4
 and others use oxidants such as DMDO
20
 
that are not commercially available. 
3.3 Results and Discussion 
 The first issue we anticipated encountering was poor or incorrect regioselectivity 




1,2-addition rather than 1,4-addition. A study by Pace
36
 suggested that an additive such 
as LiBr was necessary for 1,2-addition to occur while a conflicting study by Tomioka
37
 
found that no such additive was necessary to attain 1,2-addition for certain imines. We 
found that no additive was necessary; no 1,4-addition product was ever observed in our 
experiments. 
 The synthesis of the imines was far less of a concern initially; the majority of the 
substrates we sought to synthesize were known, some as far back as Schiff’s initial 
paper
38
 regarding imines. As a class of molecules that has been known for nearly 150 
years as of this writing, there are many different ways to synthesize imines. A general 
condensation reaction between an amine and carbonyl compound to synthesize an imine 
is shown below in Scheme 13.  
 
 
Scheme 13. General formation of an imine. 
 
 This scheme shows that the formation of the imine is reversible; a driving force must 
be imposed in order to push the reaction to completion. Water must be removed from the 
reaction by physical or chemical means. Physical removal of water is typically 
accomplished through azeotropic distillation, which imposes some important limitations. 
For one, obviously the boiling point of the solvent must be well below that of the 




that were to be used did not permit this approach, and less volatile aldehydes yielded 
unsatisfactory conversion and purity. 
 Removing water from the reaction mixture using a desiccant (anhydrous magnesium 
sulfate) provided a much more appealing solution. The desiccant could then be filtered 
off and the solution concentrated to provide the imine. This approach was adapted for 
synthesizing all of our substrates, with a few slight variations in order to obtain the 
purest material possible for the subsequent alkylation step without conducting a discrete 
purification step to streamline the process. The reaction sequence up into the secondary 
amine is shown in Scheme 14. 
 
Scheme 14. Synthesis of 5. 
 
 The results for the imine synthesis and subsequent alkylation step are shown in Table 
2, with the combined yields for both steps listed. Filtration through silica gel was 
employed to simultaneously remove the spent desiccant and any unreacted aniline. Any 
imines synthesized from cinnamaldehyde and its derivatives (entries 1-9) could be 
isolated spectroscopically pure and in high yield by partially concentrating the filtrate 
and crystallizing them out of that concentrate. Excess aniline derivative was used in this 




 Imines synthesized from non-aromatic aldehydes generally (entries 10-12) remained 
too soluble for this method to be applicable. Fortunately, any aldehyde remaining after 
filtration and concentration of the filtrate could be easily removed by co-evaporation 
with a high boiling solvent such as toluene. Excess aldehyde was used to force more 
complete conversion of the aniline derivative.  
 As imine formation is reversible, one can reasonably expect some degree of instability 
due to hydrolysis. It appeared to be the case that the unsaturated imines conjugated with 
an aromatic ring (i.e. those made from cinnamaldehyde derivatives) were mostly stable 
on the shelf in a sealed container. Those formed from enals lacking a phenyl group α- to 
the alkene, on the other hand, appeared to be less stable. These compounds were stored 
under nitrogen at -20 °C and were used as soon as possible; no discernible 
decomposition had occurred between isolation and alkylation by 
1



















 These imines were then alkylated with an organolithium reagent, also detailed above. 
These are shown in Table 2 as well; the yields given are the combined yields for the 
imine synthesis and subsequent alkylation step, which proceeded quantitatively in 
essentially all cases. The imine synthesis was a robust procedure, but nonetheless 
operationally sensitive due to the variation in substrate solubility and polarity. Some 
imines displayed diminished yield as a result of low solubility. During filtration, the less 
soluble imines were susceptible to loss along with the desiccant unless large quantities of 
solvent were used. The streamlined nature of the imine isolation procedure necessitates 
somewhat of a balancing act between isolating all of the product and obtaining the purest 
material possible.  
 The imine preparation and alkylation did not appear to be particularly sensitive to the 
aldehyde used; the lower molecular weight aldehydes (entries 10-12) lacking the phenyl 
functionality underwent the condensation to the imine and then alkylation to the N-
allylideneaniline in very much comparable yields to the other substrates. However, while 
imines prepared from these substrates did not appear to be susceptible to loss during 
filtration, they were indeed much more difficult to obtain at the same level of purity as 
those containing the phenyl moiety. 
 The N-allylideneaniline substrates were then subject to oxidation by oxone (Scheme 
15).  A mixed solvent system of acetonitrile and THF was used, with disodium EDTA 
added as an aqueous solution.  Sodium bicarbonate was then added at 4 °C.  After the 
reaction was allowed to warm up to room temperature, the Oxone was added 






Scheme 15. Oxidation of N-allylideneaniline to the α,β-unsaturated N-aryl ketonitrone. 
 
 
Figure 3. α,β-unsaturated N-aryl ketonitrones obtained using modular approach. Yields 
listed are isolated and ratios given are E:Z. Yields and ratios for 6j and 6k are estimated 
based on 
1





 Our modular approach proved to be general with regard to the oxidation step as well, 
though yields varied from adequate to good depending on the substrate (Figure 3).  
Nitrones 6j-l decomposed heavily during purification, so the yields and E:Z ratios were 
estimated from the crude 
1
H NMR spectra.  Oddly, 6b was obtained with drastically 
decreased yield when compared to nitrones 6a and 6c, despite having an ethyl group α- 
to the nitrone rather than a methyl or n-butyl. Oxidation of chlorinated amine 5g resulted 
in a poor yield of 6g as well. 
 Bartoli et al. have proposed a method for identifying the configuration of the nitrone 
for α,β-unsaturated N-aryl ketonitrones with an Sα- methyl group;25 it was reported that 
in the E- configuration the methyl group resonance peak would be found further 
downfield due to the deshielding effect of the nitrone oxygen. This shift difference was 
observed with the α,β-unsaturated N-aryl ketonitrones as well for all α-methyl species 
(all except 6b-d). In these cases, the major isomer produced was assigned as E- due to 
the further downfield methyl group resonance compared to the minor isomer. Additional 
evidence in support of these assignments and the validity of this logic was provided by 
the vinyl proton resonances.  In comparing the spectra of the two nitrone isomers of 6a 
(Figure 4), it can be seen that the Z-isomer exhibits a differential deshielding effect on 
the two vinyl protons.  In the E-isomer, the two vinyl proton resonances show a small 
chemical shift difference (Δδ ≈ 0.1 ppm) while the Z-isomer shows a much larger 
chemical shift difference (Δδ ≈ 1 ppm).  The largest chemical shift difference was found 





Figure 4. Spectra of E- and Z- isomers of nitrone 6a. 
 
 This additional spectral characteristic made it possible to tentatively assign the 
remaining α,β-unsaturated nitrones with an α- substitution other than a methyl group. 
Based on the aforementioned support, the E-isomer was the major configuration 
produced (in some cases the only isomer observed), with the exception of nitrone 6d 
with an α-phenyl group. Only one isomer was observed before and after purification, and 
based on the very large chemical shift difference between the vinyl protons the nitrone 





3.4.1 Synthetic Considerations 
General experimental concerns 
 All moisture- and air-sensitive reactions were carried out in flame-dried glassware 
under nitrogen atmosphere. Solvents were purified by passage through an activated 
alumina based solvent purification system. All commercial reagents were used as 
received. 
1
H NMR chemical shifts are reported as δ values in ppm relative to CDCl3 
(7.26 ppm), coupling constants (J) are reported in Hertz (Hz), and multiplicity follows 
convention. Deuterochloroform (CDCl3) served as an internal standard (77.36 ppm) for 
all 
13
C spectra. Flash column chromatography was performed using 60Å silica gel 
(Silicycle, 230 - 400 mesh) as the stationary phase. Thin layer chromatography (TLC) 
was performed using pre-coated glass-backed TLC plates, Silica Gel 60 F254 (EMD, 
250 μm thickness). 
Representative synthetic procedure 
 A solution of aniline (12.5 mmol) in diethyl ether (30 mL) was treated with anhydrous 
MgSO4 (5.0 g) followed by dropwise addition of the α,β-unsaturated aldehyde (12 mmol 
for cinnamaldehyde/derivatives and 15 mmol for others). The suspension was stirred at 
room temperature for 15 h under a nitrogen atmosphere before the solid was removed by 
filtration. The filtrate was concentrated under reduced pressure to give the crude N-
allylideneaniline (4) that was essentially pure by 
1
H NMR spectrum. It was used in the 
next step without purification. The N-allylideneaniline (6.50 mmol) was taken into 




dropwise with an ethereal solution of the alkyl or phenyl lithium reagent (9.75 mmol). 
The mixture was stirred at the same temperature for 20-30 min before the reaction was 
quenched by dropwise addition of aq. NH4Cl. The aqueous phase was extracted with 
ethyl acetate (2x). The combined organic phases were washed with brine, dried over 
anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The crude product 
was used for the next step without purification. The N-allyl aniline (0.26 mmol) was 
taken into a mixed solvent of THF (0.75 mL), CH3CN (2.9 mL), and 0.01 M aq. 
Na2EDTA (2.9 mL). The mixture was cooled to 4 
o
C and treated with NaHCO3 (0.108 g, 
1.29 mmol). The mixture was warmed to RT and Oxone
®
 (0.437 g, 0.71 mmol) was 
added in portions. It was stirred for an additional 20 min before ethyl acetate was added. 
The organic layer was separated and the aqueous layer was extracted with ethyl acetate 
(3x). The combined organic layers were washed with brine, dried over anhydrous 
Na2SO4, and concentrated under reduced pressure to give the crude nitrone, which was 
purified by silica gel column chromatography eluted with dichloromethane-methanol or 
ethyl acetate-acetone as a solvent system. 
3.4.2 Spectral Data for New Compounds 
(E)-N-((E)-3-phenylallylidene)aniline 




























 Yield: 74%. 
1
H NMR (300MHz, CDCl3) δ 8.12 (dd, J = 7.8, 0.6 Hz, 1H), 7.50 (m, 
2H), 7.20 (m, 2H), 7.12(m, 1H), 7.07 (m, 1H), 7.04 (d, J = 7.8 Hz, 1H), 6.93 (m, 2H), 
6.87 (m, 1H), 3.85 (s, 3H), 2.34 (s, 3H) 
13
C NMR (75MHz, CDCl3) δ 161.7, 160.7, 
151.5, 143.4, 131.6, 130.2, 129.0, 128.4, 126.7, 126.6, 125.4, 117.8, 114.3, 55.4, 17.9 
Exact mass calcd for C17H18NO [M+H]
+
: 251.1388. Found: 252.1396. 
(E)-3-methoxy-N-(3-methylbut-2-en-1-ylidene)aniline 
 Yield: 93%. 
1
H NMR (300MHz, CDCl3) δ 8.37 (d, J = 9.6 Hz, 1H), 7.25 (m, 1H), 
6.78-6.66 (m, 3H), 6.21 (m, 1H), 3.82, (s, 3H), 2.02 (m, 3H), 1.97 (d, J = 1.2 Hz, 3H) 
13
C NMR (75MHz, CDCl3) δ 160.6, 159.3, 154.4, 150.9, 130.1, 126.5, 113.2, 111.6, 
107.1, 55.6, 27.2, 19.3 Exact mass calcd for C16H16NO [M+H]
+







 Yield: 91%. 
1
H NMR (300MHz, CDCl3) δ 8.37 (d, J = 9.6 Hz, 1H), 7.35 (m, 2H), 7.18 
(m, 1H), 7.11 (m, 2H), 6.23 (m, 1H), 2.02 (m, 3H), 1.97 (m, 3H) 
13
C NMR (75MHz, 
CDCl3) δ 159.2, 153.0, 150.6, 129.4, 126.6, 125.8, 121.2, 27.2, 19.3 Exact mass calcd 
for C11H14N [M+H]
+
: 160.1126. Found: 160.1121. 
(E)-N-(4-phenylbut-3-en-2-yl)aniline (5a) 





 Yield: 96%. 
1
H NMR (300MHz, CDCl3) δ 7.40-7.12 (m, 5H), 7.08 (m, 2H), 6.67 (m, 
2H), 6.59 (dd, J = 15.9, 1.2 Hz, 1H), 4.2 (m, 1H), 3.56 (br. S, 1H), 2.19 (s, 3H), 1.46 (d, 
J = 6.6 Hz, 3H)
 13
C NMR (75MHz, CDCl3) δ 145.7, 137.3, 133.7, 130.4, 129.6, 128.8, 







H NMR (300MHz, CDCl3) δ 7.30 (m, 5H), 6.98 (m, 2H), 6.58 (m, 3H), 
6.23 (dd, J = 16.2, 6 Hz, 1H), 4.12 (m, 1H), 3.58 (br. s, 1H), 2.24 (s, 3H), 1.40 (d, J = 
6.6 Hz, 3H) 
13
C NMR (75MHz, CDCl3) δ 145.4, 137.4, 133.8, 130.0, 129.5, 128.8, 
127.6, 126.9, 126.6, 114.0, 51.5, 22.4, 20.7 Exact mass calcd for C17H20N [M+H]
+
: 







 Yield: 99%. 
1
H NMR (300MHz, CDCl3) δ 7.30 (m, 5H), 7.09 (m, 2H), 6.55 (m, 3H), 
6.18 (dd, J = 15.9, 5.7 Hz, 1H), 4.10 (m, 1H), 3.73 (br. S, 1H), 1.41 (d, J = 6.6 Hz, 3H)
 
13
C NMR (75MHz, CDCl3) δ 146.3, 137.1, 132.9, 129.9, 129.3, 128.9, 127.8, 126.7, 
122.2, 114.8, 51.4, 22.4 Decomposed in mass spectrometry analysis. 
(E)-N-(1-phenylpent-1-en-3-yl)aniline (5b) 
 Yield: 98%. 
1
H NMR (300MHz, CDCl3) δ 7.4-7.13 (m, 7H), 6.67 (m, 3H), 6.59 (d, J = 
15.9 Hz, 1H), 6.14 (dd, J = 15.9, 6.3 Hz, 1H), 3.90 (m, 1H), 3.75 (br. s, 1H), 1.73 (m, 
2H), 1.04 (t, J = 7.2 Hz, 3H)
 13
C NMR (75MHz, CDCl3) δ 148.0, 137.4, 132.3, 130.7, 
128.8, 127.6, 126.7, 117.5, 113.7, 57.5, 29.4, 10.8. C17H20N [M+H]
+
: 238.1596. Found: 
238.1607. 
(E)-N-(1-phenylhept-1-en-3-yl)aniline (5c) 










 Yield: 98%. 
1
H NMR (300MHz, CDCl3) δ 7.29 (m, 2H), 7.16 (m, 2H), 6.84 (m, 2H), 
6.66 (m, 3H), 6.52 (d, J = 15.9 Hz, 1H), 6.08 (dd, J = 15.9, 6 Hz, 1H), 4.13 (m, 1H), 
3.80 (s, 3H), 3.70 (br. S, 1H), 1.40 (d, J = 6.6 Hz, 3H) 
13




159.4, 147.8, 131.3, 130.1, 129.5, 129.0, 127.8, 114.6, 114.3, 113.7, 55.6, 51.2, 22.5 
C17H20NO [M+H]
+
: 254.1545. Found: 254.1548. 
(E)-N-(4-(4-methoxyphenyl)but-3-en-2-yl)-2-methylaniline (5i) 
 Yield: 99%. 
1
H NMR (300MHz, CDCl3) δ 7.30 (m, 2H), 7.08 (m, 2H), 6.84 (m, 2H), 
6.66 (m, 2H), 6.53 (d, J = 15.9 Hz, 1H), 6.11 (dd, J = 15.9, 5.7 Hz, 1H), 4.18 (m, 1H), 
3.80 (s, 3H), 3.55 (br. s, 1H), 2.18 (s, 3H), 1.44 (d, J = 6.6 Hz, 3H) ) 
13
C NMR (75MHz, 
CDCl3) δ 159.4, 145.72, 131.5, 130.1, 129.0, 127.8, 127.4, 122.0, 117.1, 114.2, 111.2, 
55.6, 51.1, 227, 18.0. Decomposed in mass spectrometry analysis. 
(E)-N-(pent-3-en-2-yl)aniline (5j) 





 Yield: 95%. 
1
H NMR (300MHz, CDCl3) δ 7.05 (t, J = 8.1 Hz, 1H), 6.20 (m, 3H), 5.06 
(m, 1H), 4.13 (m, 1H), 3.76 (m, 1H), 3.62 (br. S, 1H) 1.74 (d, J = 1.5 Hz, 3H), 1.70 (d, J 
= 2.4 Hz, 3H), 1.24 (d, J = 6.3 Hz, 3H)  
13
C NMR (75MHz, CDCl3) δ 161.0, 149.4, 
133.0, 130.1, 129.7, 106.8, 102.6, 99.3, 55.3, 47.6, 26.0, 22.4, 18.5 C12H16NO [M+H]
+
: 
206.1545. Found: 206.1554. 
(E)-N-(3-methylpent-3-en-2-yl)aniline (5l) 








(Z)-N-((E)-4-phenylbut-3-en-2-ylidene)aniline oxide (Z-6a) 
 
1
H NMR (300MHz, CDCl3) δ 8.05 (d, 1H, J = 16.5 Hz), 7.62 (m, 2H), 7.29-7.52 (m, 
8H), 7.12 (d, J = 16.8 Hz, 2H), 2.14 (s, 3H) 
13
C NMR (75MHz, CDCl3) δ 138.1, 136.5, 
129.9, 129.8, 129.7, 129.6, 129.2, 128.0, 128.0, 124.0, 120.8, 16.7 Exact mass calcd for 
C16H16NO [M+H]
+
: 238.1232. Found: 238.1221. 
(E)-N-((E)-4-phenylbut-3-en-2-ylidene)aniline oxide (E-6a) 
 
1
H NMR (300MHz, CDCl3) δ 7.48 (m, 3H), 7.41 (m, 2H), 7.19-7.31 (m, 5H), 6.8 (d, J 
= 18 Hz, 1H), 6.71 (d, J = 15.9 Hz, 1H), 2.54 (s, 3H) 
13
C NMR (75MHz, CDCl3) δ 
148.4, 145.7, 136.3, 133.3, 129.8, 129.8, 129.2, 129.1, 127.2, 124.8, 121.3, 13.7 
C16H16NO [M+H]
+
: 238.1232. Found: 238.1224 
(E)-2-methyl-N-((E)-4-phenylbut-3-en-2-ylidene)aniline oxide (6e) 
 Yield: 51% 2.7:1 E:Z. 
1
H NMR (300MHz, CDCl3) δ 7.40-7.15 (m, 9H), 6.82 (d, J = 
15.9 Hz, 1H), 6.52 (d, J = 15.9 Hz, 1H), 2.54 (s, 3H), 2.25 (s, 3H)
 13
C NMR (75MHz, 
CDCl3) δ 148.3, 144.6, 136.2, 133.4, 131.7, 129.6, 129.1, 129.1, 127.4, 127.2, 124.6, 
120.6,17.0, 12.9 Exact mass calcd for C17H18NO [M+H]
+
: 252.1388. Found: 252.1379. 
(E)-4-methyl-N-((E)-4-phenylbut-3-en-2-ylidene)aniline oxide (6f) 
 Yield: 67%, 3.7:1 E:Z. 
1
H NMR (300MHz, CDCl3) δ 7.26 (m, 9H), 6.77 (m, 2H), 2.51 
(d, J = 2.1 Hz, 3H), 2.42 (d, J = 2.4 Hz, 3H). 
13
C NMR (75MHz, CDCl3) δ 147.9, 143.4, 
139.9, 136.4, 132.8, 130.2, 129.1, 129.0, 127.1. 124.5, 121.5. Exact mass calcd for 
C17H18NO [M+H]
+






(E)-4-chloro-N-((E)-4-phenylbut-3-en-2-ylidene)aniline oxide (6g) 
 Yield: 34%, 2:1 E:Z. 
1
H NMR (300MHz, CDCl3) δ 7.47 (m, 2H), 7.36 (m, 2H), 7.27 
(m, 4H), 6.84 (d, J =15.9 Hz, 1H), 6.69 (d, J = 15.9 Hz, 1H), 2.52 (s, 3H) 
13
C NMR 
(75MHz, CDCl3) δ 148.5, 144.2, 136.1, 135.6, 133.6, 130.0, 129.4, 129.2, 127.3, 126.2, 
120.9, 13.8. Exact mass calcd for C16H15ClNO [M+H]
+
: 272.0842. Found: 272.0831. 
(E)-N-((E)-1-phenylpent-1-en-3-ylidene)aniline oxide (6b) 
 Yield: 22%, 3.3:1 E:Z. 
1
H NMR (300MHz, CDCl3) δ 7.48 (m, 3H), 7.40 (m, 3H), 7.25 
(m, 4H), 6.80 (d, J = 15.9, Hz, 1H), 6.64 (d, J = 16.2 Hz, 1H), 3.03 (q, J = 7.5 Hz, 2H), 
1.33 (t, J = 7.5)
 13
C NMR (75MHz, CDCl3) δ 152.6, 145.9, 138.0, 132.4, 129.7, 129.7, 
129.1, 127.2, 124.8, 120.4, 20.4, 10.4. Exact mass calcd for C17H18NO [M+H]
+
: 
252.1388. Found: 252.1371. 
 (Z)-N-((E)-1-phenylhept-1-en-3-ylidene)aniline oxide (Z-6c) 
 Yield: 82% 2:1 E:Z 
1
H NMR (300MHz, CDCl3) δ 7.92 (d, J = 16.8 Hz, 1H), 7.62 (m, 
2H), 7.47 (m, 3H), 7.36 (m, 3H), 7.19 (d, J = 68 Hz, 1H), 2.46 (m, 2H), 1.51 (m, 2H), 
1.25 (m, 2H), 0.79 (t, J = 7.2 Hz, 3H)
 13
C NMR (75MHz, CDCl3) δ 149.8, 146.3, 138.1, 
136.6, 129.8, 129.6, 129.5, 129.2, 127.9, 123.8, 119.6, 30.9, 29.6, 22.9, 13.8. 
(E)-N-((E)-1-phenylhept-1-en-3-ylidene)aniline oxide (E-6c) 
 
1
H NMR (300MHz, CDCl3) δ 7.48 (m, 3H), 7.39 (m, 2H), 7.25 (m, 5H), 6.79 (d, J = 
15.9 Hz, 1H), 6.65 (d, J = 15.9 Hz, 1H), 3.00 (m, 2H), 1.74 (m, 2H), 1.57 (m, 2H), 1.02 
(t, J = 7.2 Hz, 3H) 
13
C NMR (75MHz, CDCl3) δ 151.7, 145.7, 136.3, 132.5, 129.6, 
129.6, 129.0, 129.0, 127.1, 124.7, 120.8, 28.0, 16.7, 23.3, 14.2. Exact mass calcd for 
C19H22NO [M+H]
+




(E)-N-((E)-1,3-diphenylallylidene)aniline oxide (6d) 
 Yield: 52%, ≥5:1 E:Z.  1H NMR (300MHz, CDCl3) δ 8.18 (d, J = 16.5 Hz, 1H), 7.53 
(m, 3H), 7.38-7.14 (m, 12H), 6.71 (d, J = 16.2 Hz, 1H) ) 
13
C NMR (75MHz, CDCl3) δ 
150.2, 147.4, 141.2, 136.6, 133.1, 131.2, 129.7, 129.3, 129.1, 129.0, 128.9, 128.8, 128.0, 
125.2, 122.3 Exact mass calcd for C21H18NO [M+H]
+
: 300.1388. Found: 300.1396. 
(Z)-N-((E)-4-(4-methoxyphenyl)but-3-en-2-ylidene)aniline oxide (Z-6h) 
 Yield: 80%, 4:1 E:Z. 
1
H NMR (300MHz, CDCl3) δ 7.93 (d, J = 16.5 Hz, 1H), 7.57 (d, 
J = 8.7 Hz, 2H), 7.44 (m, 5H), 7.08 (d, J = 16.5 Hz, 1H), 6.91 (d, J = 8.7 Hz, 2H), 3.84 
(s, 3H), 2.11 (s, 3H)
 13
C NMR (75MHz, CDCl3) δ 161.0, 146.6, 145.2, 137.9, 129.8, 







H NMR (300MHz, CDCl3) δ 7.45 (m, 5H), 7.17 (d, J = 8.7 Hz, 2H), 6.79 (m, 3H), 
6.57 (d, J = 15.9 Hz), 3.78 (s, 3H), 2.52 (s, 3H) )
 13
C NMR (75MHz, CDCl3) δ 160.5, 
148.4, 145.8, 132.9, 129.7, 129.7, 129.1, 128.7, 124.8, 119.3, 114.6, 55.6, 13.6. 
C17H18NO2 [M+H]
+
: 268.1338.  Found: 268.1350. 
 (Z)-N-((E)-4-(4-methoxyphenyl)but-3-en-2-ylidene)-2-methylaniline oxide (Z-6i) 
 Yield: 49%, 2:1 E:Z. 
1
H NMR (300MHz, CDCl3) δ 7.94 (d, J = 16.5 Hz, 1H), 7.57 (m, 
2H), 7.30 (m, 3H), 7.22 (m, 1H), 7.08 (d, J = 16.5 Hz, 1H), 6.91 (m, 2H), 3.84 (s, 3H), 
2.30 (s, 3H), 2.02 (s, 3H)
 13
C NMR (75MHz, CDCl3) δ 161.0, 145.6, 145.5, 137.9, 131.8, 
129.5, 129.3, 129.2, 127.5, 123.9, 118.1, 114.7, 55.7, 16.9, 15.7. Exact mass calcd for 
C18H20NO2 [M+H]
+




(E)-N-((E)-4-(4-methoxyphenyl)but-3-en-2-ylidene)-2-methylaniline oxide (E-6i) 
 
1
H NMR (300MHz, CDCl3) δ 7.32 (m, 4H), 7.15 (m, 2H), 6.78 (m, 3H), 6.37 (d, J = 
14.7 Hz), 3.78 (s, 3H), 2.53 (s, 3H), 2.25 (s, 3H). 
(E)-N-((E)-pent-3-en-2-ylidene)aniline oxide (6j) 
 Yield: 70% estimated, ≥5:1 E:Z. 1H NMR (300MHz, CDCl3) δ 7.44 (m, 3H), 7.33 (m, 
2H), 6.05 (m, 2H), 2.40 (s, 3H), 1.75 (d, J = 5.4 Hz, 3H). 
13
C NMR (75MHz, CDCl3) δ 
132.5, 129.8, 129.7, 129.5, 125.1, 124.6, 123.9, 19.3, 13.7. Exact mass calcd for 
C11H14NO [M+H]
+
: 176.1075. Found: 176.1079. 
(E)-3-methoxy-N-(4-methylpent-3-en-2-ylidene)aniline oxide (6k)  
 Yield: 70% estimated, ≥5:1 E:Z.  1H NMR (300MHz, CDCl3) δ 7.28 (m, 1H), 6.91 (m, 
3H), 5.66 (m, 1H), 3.80 (s, 1H), 2.47 (s, 3H), 1.83 (d, J = 0.9 Hz, 3H), 1.70 (d, J = 1.2 
Hz, 3H) Exact mass calcd for C13H20NO [M+H]
+
: 206.1545. Found: 206.1554. 
(E)-N-((E)-3-methylpent-3-en-2-ylidene)aniline oxide (6k) 
 Yield: 20%. 
1
H NMR (300MHz, CDCl3) δ 7.32 (m, 6H), 2.38 (t, J = 1.2 Hz, 3H), 1.52 
(s, 3H), 1.46 (d, J = 6.6 Hz)
 13
C NMR (75MHz, CDCl3) δ 131.3, 129.7, 129.1, 129.0, 
124.1, 123.6, 123.3 Exact mass calcd for C12H16NO [M+H]
+








 Our group recently discovered and developed a method for producing C3-quaternary 
indolenines in good yields from the reaction between α,β-Unsaturated N-aryl 
ketonitrones and activated alkynes. The reaction was optimized, and after exploring the 
substrate scope of the reaction it was found to be relatively general with varying yields. 
The α,β-Unsaturated N-aryl ketonitrones were synthesized using the aforementioned 
method developed in our lab as well as the one developed by Bartoli et al. Even with the 
use of these two very different approaches, we were very much limited in our range of 
nitrones, so we sought to develop an efficient and straightforward technique for 
accessing a wider range of nitrone substrates for this reaction as well as other potential 
synthetic applications. Unfortunately, after a brief investigation we found that these 
nitrones could not be used to synthesize C3-quaternary indolenines. It is hoped that with 
a deeper investigation a set of reaction conditions could be found to remedy this 
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Aliphatic Impurities
~1.25 ppm
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Aliphatic Impurities
1.26 ppm
Water ~1.6 ppm
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